US Patent Issued to BIOTRONIK on Dec. 2 for "Implant with antiproliferative active substance limited to abluminal side and method of production" (German Inventor)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,207, issued on Dec. 2, was assigned to BIOTRONIK AG (Buelach, Switzerland).

"Implant with antiproliferative active substance limited to abluminal side and method of production" was invented by Andre Goepfert (Alt Sammit, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "An implant, such as an endovascular implant, has degradable main body that defines a lumen. A degradable coating including at least one degradable polymer substantially completely encloses the main body on its luminal and abluminal sides. An antiproliferative active substance is upon the degradable coating only on the abluminal side of the main body."

The patent was filed on Aug...